Published Date: 26-May-2023
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Neurovascular Catheters Market size is expected to reach $4.6 Billion by 2029, rising at a market growth of 6.8% CAGR during the forecast period.
The Embolization Catheters market is leading the Global Neurovascular Catheters Market by Type in 2022; thereby, achieving a market value of $1.3 billion by 2029. This is because embolization is a medical procedure where embolic agents are introduced through a catheter into specific blood vessels to obstruct blood flow that feeds a tumor or malformation. Neurovascular embolization catheters are utilized in the medical field to manage abnormal bleeding by obstructing the vessels that supply blood to a tumor or to treat aneurysms.
The Ambulatory Surgical Centers market would register a CAGR of 7.3% during (2023 - 2029). This is owing to the various benefits ASCs provide to its patients, such as reduced procedure time and discharge on the same day. Advanced and minimally invasive surgical procedures have made it possible to perform most neurosurgeries at ASCs. In addition, ASCs offer cost-effective healthcare options to patients as compared to hospitals.
The Brain Aneurysm market acquired the highest revenue share in the Global Neurovascular Catheters Market by Application in 2022; thereby, achieving a market value of $1.7 billion by 2029. This is because brain aneurysms, also known as intracranial aneurysms, can result in cerebral hemorrhage due to the leakage or rupture of blood vessels within the brain. Hypertension, smoking, blood vessel injury or trauma, genetic predisposition, and certain blood infections are all factors that can contribute to the development of intracranial aneurysms.
The North America market dominated the Global Neurovascular Catheters Market by Region in 2022; thereby, achieving a market value of $1.7 billion by 2029. The Europe market is anticipated to grow at a CAGR of 6.4% during (2023 - 2029). Additionally, The Asia Pacific market would showcase a CAGR of 7.3% during (2023 - 2029).
Full Report: https://www.kbvresearch.com/neurovascular-catheters-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Stryker Corporation, Terumo Corporation, Integer Holdings Corporation, Penumbra, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, RAUMEDIC AG (REHAU Industries SE & Co. KG).
By End Use
Unique Offerings from KBV Research
North America Neurovascular Catheters Market size & Opportunities 2023-2029
Europe Neurovascular Catheters Market & Growth Forecast 2023-2029
Asia Pacific Neurovascular Catheters Market Share & Industry Outlook to 2029
LAMEA Neurovascular Catheters Market Growth, Trends & Forecasts 2023-2029